TIR GLP-1+GIP

TIR is a new peptide that combines the actions of GLP-1 and GIP, demonstrating strong potential in research on body weight control, glycemic regulation, and metabolic health. It works by stimulating glucose-dependent insulin secretion, suppressing glucagon, and regulating appetite, all of which support weight reduction and improved lipid metabolism. Animal studies and early clinical research also indicate benefits for cardiovascular health, kidney protection, and enhanced pancreatic beta-cell function.

The peptide also exhibits neuroprotective properties, reducing oxidative stress and inflammation in the brain, which may be relevant in neurodegenerative conditions. Additionally, it supports gastrointestinal health by improving intestinal motility, microbiota composition, and gut barrier integrity. Thanks to its broad spectrum of activity, TIR is considered one of the most promising candidates in research related to obesity, type 2 diabetes, and other metabolic disorders.

Laboratory reagent – for research purposes only

This product is classified as a chemical reagent intended exclusively for research purposes and should be handled by qualified professionals in laboratory conditions. It is not a dietary supplement, medication, or food product and is not intended for human consumption. All information provided is for educational purposes only.